Literature DB >> 24966958

Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma.

Jing Ji1, Xing Wei1, Yueling Wang1.   

Abstract

BACKGROUND: Both the expression of embryonic stem cells (ESCs) markers (Sox2, Oct4) and the Wnt signal pathway (β-catenin) are crucial for progression of various human malignancies. The purpose of this study was to investigate the clinicopathologic significance of Sox2, Oct4 and β-catenin in cervical squamous cell carcinoma (CSCC) and to study their correlation with the occurrence and prognosis.
METHODS: Sox2, Oct4 and β-catenin were assessed using immunohistochemistry in normal cervix tissues (n=28) and invasive cervical squamous cell carcinoma (n=43). Associations of Sox2, Oct4 and β-catenin levels with clinicopathological characteristics and with overall survival were studied using uni- and multivariate analysis.
RESULTS: The expression levels of Sox2, Oct4 and β-catenin were highly increased in CSCC compared with the normal cervix tissues. The ESCs markers expression (Sox2 and Oct4) correlated significantly with β-catenin expression. High expression of Sox2, but not that of Oct4 or β-catenin, was correlated with poorer differentiation (P<0.05). Furthermore, Sox2 expression was significantly correlated with patients' status of survival in advanced CSCC (P<0.05), whereas there was no significant finding in Oct4 or β-catenin expression.
CONCLUSIONS: These findings provide evidence that both ESCs biomarkers (Sox2, Oct4) and Wnt signal pathway (β-catenin) are activated in CSCC. Sox2 can be regarded as a novel predictor of poor prognosis for CSCC patients.

Entities:  

Keywords:  Oct4; Sox2; cervical squamous cell carcinoma; immunohistochemistry; prognosis; β-catenin

Mesh:

Substances:

Year:  2014        PMID: 24966958      PMCID: PMC4069924     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

Review 1.  Wnt signaling in stem and cancer stem cells.

Authors:  Jane D Holland; Alexandra Klaus; Alistair N Garratt; Walter Birchmeier
Journal:  Curr Opin Cell Biol       Date:  2013-01-21       Impact factor: 8.382

Review 2.  Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.

Authors:  Bryan D White; Andy J Chien; David W Dawson
Journal:  Gastroenterology       Date:  2011-12-08       Impact factor: 22.682

Review 3.  The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.

Authors:  Taj D King; Mark J Suto; Yonghe Li
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

4.  Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.

Authors:  Fang Yang; Yina Gao; Jingshu Geng; Di Qu; Qiuyue Han; Jiping Qi; Gongyan Chen
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 5.  Neuroblastoma stem cells - mechanisms of chemoresistance and histone deacetylase inhibitors.

Authors:  M A Khalil; J Hrabeta; S Cipro; M Stiborova; A Vicha; T Eckschlager
Journal:  Neoplasma       Date:  2012       Impact factor: 2.575

6.  Identification and expansion of the tumorigenic lung cancer stem cell population.

Authors:  A Eramo; F Lotti; G Sette; E Pilozzi; M Biffoni; A Di Virgilio; C Conticello; L Ruco; C Peschle; R De Maria
Journal:  Cell Death Differ       Date:  2007-11-30       Impact factor: 15.828

7.  Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.

Authors:  Jun Ruan; Bingbing Wei; Zhuoqun Xu; Shudong Yang; You Zhou; Minhong Yu; Jiabei Liang; Ke Jin; Xing Huang; Peng Lu; Huan Cheng
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

Review 8.  Wnt signaling in adult intestinal stem cells and cancer.

Authors:  Michaela Krausova; Vladimir Korinek
Journal:  Cell Signal       Date:  2013-12-02       Impact factor: 4.315

9.  Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion.

Authors:  Frederic Lluis; Elisa Pedone; Stefano Pepe; Maria Pia Cosma
Journal:  Cell Stem Cell       Date:  2008-11-06       Impact factor: 24.633

10.  Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.

Authors:  Weiren Luo; Siyi Li; Bailu Peng; Yanfen Ye; Xubin Deng; Kaitai Yao
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

View more
  17 in total

Review 1.  Recent advances in the study of HPV-associated carcinogenesis.

Authors:  Liyan Jin; Zhi-Xiang Xu
Journal:  Virol Sin       Date:  2015-04-20       Impact factor: 4.327

2.  Primary cultures of human colon cancer as a model to study cancer stem cells.

Authors:  Sergey Koshkin; Anna Danilova; Grigory Raskin; Nikolai Petrov; Olga Bajenova; Stephen J O'Brien; Alexey Tomilin; Elena Tolkunova
Journal:  Tumour Biol       Date:  2016-07-23

3.  SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading.

Authors:  Kazimierz Pityński; Tomasz Banas; Milosz Pietrus; Katarzyna Milian-Ciesielska; Artur Ludwin; Krzysztof Okon
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 4.  Advancements in Cancer Stem Cell Isolation and Characterization.

Authors:  Heena Jariyal; Chanchal Gupta; Vedika Sandeep Bhat; Jayant Ramakant Wagh; Akshay Srivastava
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

Review 5.  Potential Gene Interactions in the Cell Cycles of Gametes, Zygotes, Embryonic Stem Cells and the Development of Cancer.

Authors:  Gregor Prindull
Journal:  Front Oncol       Date:  2015-09-23       Impact factor: 6.244

6.  TAT-mediated si-hWAPL inhibits the invasion and metastasis of cervical cancer stem cells.

Authors:  Pijun Gong; Chunyan Hu; Xi Zhou; Renxiao Wang; Zhao Duan
Journal:  Exp Ther Med       Date:  2017-09-29       Impact factor: 2.447

7.  Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity.

Authors:  Simone Aparecida de Bessa Garcia; Ana Carolina Pavanelli; Natália Cruz E Melo; Maria Aparecida Nagai
Journal:  Int J Mol Med       Date:  2017-02-21       Impact factor: 4.101

8.  Relationship of Oct-4 to malignant stage: a meta-analysis based on 502 positive/high Oct-4 cases and 522 negative/low case-free controls.

Authors:  Beilong Zhong; Yan Lin; Yingrong Lai; Fangfang Zheng; Xiaobin Zheng; Rijiao Huang; Weilin Yang; Zhenguang Chen
Journal:  Oncotarget       Date:  2016-01-12

9.  Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.

Authors:  Bo Wook Kim; Hanbyoul Cho; Chel Hun Choi; Kris Ylaya; Joon-Yong Chung; Jae-Hoon Kim; Stephen M Hewitt
Journal:  BMC Cancer       Date:  2015-12-26       Impact factor: 4.430

Review 10.  Cancer stem cells (CSCs), cervical CSCs and targeted therapies.

Authors:  Ruixia Huang; Einar K Rofstad
Journal:  Oncotarget       Date:  2017-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.